AI-CVD vs Rapid RV/LV

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI-CVD

by HeartLung AI

Rapid RV/LV

by RapidAI

AI Verdict

While both AI-CVD and Rapid RV/LV leverage AI for cardiac assessment from CT scans, their primary focus areas differ. AI-CVD offers a comprehensive, opportunistic screening platform for various cardiovascular and multisystem diseases, providing a broad range of measurements for overall risk stratification. Rapid RV/LV, on the other hand, is specifically designed for rapid assessment of pulmonary embolism severity by focusing on right and left ventricle ratios from CTPA scans, making it a more specialized tool for acute PE cases.

Choose AI-CVD if…

Choose AI-CVD if your institution aims to proactively identify a broad spectrum of hidden cardiovascular and multisystem disease risks in patients undergoing routine chest and abdominal CT scans. This tool is ideal for opportunistic screening, leveraging existing imaging data without additional radiation or contrast, to detect conditions like coronary artery calcium and cardiac chamber abnormalities early.

View AI-CVD →

Choose Rapid RV/LV if…

Choose Rapid RV/LV if your priority is the rapid and accurate assessment of pulmonary embolism severity in patients presenting with suspected PE and undergoing CTPA. This AI tool is specifically designed to quickly calculate the critical right-to-left ventricle ratio, aiding clinicians in urgent triage and treatment decisions for pulmonary embolism cases.

View Rapid RV/LV →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AI-CVD	Rapid RV/LV
Pricing	Unknown	Contact vendor for pricing information.
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rapid RV/LV

Rapid RV/LV emphasizes rapid results within minutes and aims to reduce inter-rater variability, suggesting a streamlined and efficient user experience for a specific, critical measurement. While AI-CVD focuses on opportunistic screening, there is no explicit mention of its speed or ease of use in comparison to Rapid RV/LV's stated benefits for urgent PE assessment.

Clinical Value

AI-CVD

AI-CVD offers a broader range of quantitative imaging measurements for cardiovascular and multisystem diseases, including CAC scoring, aortic and mitral valve analysis, and cardiac chamber volumetry, enabling early detection of hidden health risks. Rapid RV/LV, while crucial for pulmonary embolism severity assessment, focuses on a single, albeit important, metric (RV/LV ratio). AI-CVD's comprehensive approach suggests greater clinical value for general cardiovascular risk stratification.

Pricing & Value

Tie

Neither tool provides transparent pricing information in the given data. AI-CVD offers a free trial, which could be seen as an added value, but without pricing for either, a direct comparison of overall value is not possible. RapidAI states to contact the vendor for pricing information.

Enterprise Readiness

Rapid RV/LV

RapidAI, the company behind Rapid RV/LV, boasts over 2,500 customers and a broader platform (Rapid PE solution) that includes triage, notification, and mobile app capabilities, indicating a more established and integrated enterprise solution. AI-CVD, while FDA-cleared and HIPAA compliant, does not provide comparable metrics for customer base or platform integration.

Innovation

AI-CVD

AI-CVD focuses on opportunistic screening for a wide array of cardiovascular and multisystem diseases using existing CT scans, without requiring additional imaging or workflow disruption. This broad, proactive screening approach across multiple conditions represents a more innovative application of AI in early disease detection compared to Rapid RV/LV's more focused, albeit critical, application for PE severity.

Support & Docs

Tie

Both tools are FDA-cleared and HIPAA compliant, implying a level of regulatory and data handling maturity. However, specific details regarding customer support, training, or documentation for either product are not provided in the given information, making it impossible to determine a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AI-CVD	Rapid RV/LV
Name	AI-CVD	Rapid RV/LV
Company	HeartLung Corporation	RapidAI (formerly iSchemaView)
Key Functionality	Opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks.	Rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans.
Core Measurements/Analysis	Coronary Artery Calcium (CAC) scoring, Aortic wall, aortic valve, and mitral valve calcium analysis, Cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle), Epicardial fat volumetry, Aorta and pulmonary artery sizing	Automated measurement of right and left ventricle diameters, Calculation of RV/LV ratio
Categories	Cardiology AI	Cardiology AI, Radiology & Imaging AI

Videos

Demos, reviews, and walkthroughs featuring AI-CVD and Rapid RV/LV.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications and disease focuses of AI-CVD and Rapid RV/LV?

AI-CVD is designed for opportunistic screening of cardiovascular and multisystem diseases using existing CT scans, aiming for early detection of hidden health risks like coronary heart disease, heart failure, atrial fibrillation, stroke, osteoporosis, liver steatosis, and diabetes. Rapid RV/LV, on the other hand, is specifically an AI tool for the rapid assessment of pulmonary embolism (PE) severity by measuring right and left ventricle ratios from CTPA scans.

What types of CT scans are compatible with each tool, and do they require additional imaging?

AI-CVD utilizes existing chest and abdominal CT scans for its analysis and explicitly states that it requires no additional imaging, radiation, contrast, or workflow disruption. Rapid RV/LV is designed to analyze CTPA (CT Pulmonary Angiography) scans to assess PE severity.

What specific measurements and analyses do AI-CVD and Rapid RV/LV provide?

AI-CVD offers automated CT-derived measurements including Coronary Artery Calcium (CAC) scoring, aortic and mitral valve calcium analysis, cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle), epicardial fat volumetry, and aorta and pulmonary artery sizing. Rapid RV/LV focuses on automated measurement of right and left ventricle diameters and the calculation of the RV/LV ratio, providing annotated images with these measurements.

What is the speed of results for each tool?

Rapid RV/LV provides rapid results, typically within minutes of the CTPA scan, which is crucial for acute conditions like pulmonary embolism. The provided information for AI-CVD does not specify a turnaround time for its results.